Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer.
作者信息
Nemunaitis John, Stanbery Laura, Walter Adam, Rocconi Rodney, Stephens Philip
机构信息
Gradalis, Inc, Dallas, TX, United States.
ProMedica, Toledo, OH, United States.
出版信息
Oncol Rev. 2023 Sep 20;17:11471. doi: 10.3389/or.2023.11471. eCollection 2023.
Abstract
摘要
Zotero 插件